Evidence map›Paper›PMID 25644938›Full record

ArticleAddiction (Abingdon, England)2015

Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.

Elizabeth Evans, Libo Li, Jeong Min, David Huang, Darren Urada, Lei Liu, Yih-Ing Hser, Bohdan Nosyk

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 4 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 4 syntheses or guidelines pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Elizabeth EvansUCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA.
Libo LiUCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA.
Jeong MinBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
David HuangUCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA.
Darren UradaUCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA.
Lei LiuNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Yih-Ing HserUCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA.
Bohdan NosykBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
OASIS Clinic · USAIDS Vancouver · CANorthwestern University · USSimon Fraser University · CA

Funding

STATISTICAL SUPPORT/DATA MANAGEMENT COREP30DA016383 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSER, YIH-ING · 2005 to 2015
$8.6M
Seek and Treat for Optimal Prevention of HIV & AIDS (STOP HIV/AIDS) in BCR01DA036307 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MONTANER, JULIO SERGIO GONZALEZ · 2013 to 2017
$3.0M
A Comparison of Methadone Treatment Systems in California and British ColumbiaR01DA031727 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NOSYK, BOHDAN · 2011 to 2013
$512k
An empirical investigation into recovery from illicit drug abuse using recurrentR01DA032551 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MONTANER, JULIO SERGIO GONZALEZ, NOSYK, BOHDAN · 2012 to 2014
$500k
NIDA NIH HHS P30 DA016383NIDA NIH HHS R01 DA031727NIDA NIH HHS R01 DA032551NIDA NIH HHS R01 DA036307
6 · The paper itself

Abstract

aimsTo estimate mortality rates among treated opioid-dependent individuals by cause and in relation to the general population, and to estimate the instantaneous effects of opioid detoxification and maintenance treatment (MMT) on the hazard of all-cause and cause-specific mortality.

designPopulation-based treatment cohort study.

settingLinked mortality data on all individuals first enrolled in publicly funded pharmacological treatment for opioid dependence in California, USA from 2006 to 2010.

participantsA total of 32 322 individuals, among whom there were 1031 deaths (3.2%) over a median follow-up of 2.6 years (interquartile range = 1.4-3.7). MEASUREMENTS: The primary outcome was mortality, indicated by time to death, crude mortality rates (CMR) and standardized mortality ratios (SMR).

findingsIndividuals being treated for opioid dependence had a more than fourfold increase of mortality risk compared with the general population [SMR = 4.5, 95% confidence interval (CI) = 4.2, 4.8]. Mortality risk was higher (1) when individuals were out-of-treatment (SMR = 6.1, 95% CI = 5.7, 6.5) than in-treatment (SMR = 1.8, 95% CI = 1.6, 2.1) and (2) during detoxification (SMR = 2.4, 95% CI = 1.5, 3.8) than during MMT (SMR = 1.8, 95% CI = 1.5, 2.1), especially in the 2 weeks post-treatment entry (SMR = 5.5, 95% CI = 2.7, 9.8 versus SMR = 2.5, 95% CI = 1.7, 4.9). Detoxification and MMT both independently reduced the instantaneous hazard of all-cause and drug-related mortality. MMT preceded by detoxification was associated with lower all-cause and other cause-specific mortality than MMT alone.

conclusionsIn people with opiate dependence, detoxification and methadone maintenance treatment both independently reduce the instantaneous hazard of all-cause and drug-related mortality.

Indexed as

AdolescentAdultAge of OnsetCaliforniaCohort StudiesFemaleHumansMaleMethadoneNarcoticsOpiate Substitution TreatmentOpioid-Related DisordersRisk FactorsYoung AdultMethadoneNarcoticsAdministrative datadetoxification and maintenance treatmentlongitudinal designmortalityopioid dependence

Identifiers

PMID25644938
PMCPMC4452110
OpenAlexW2121605499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.